Austin location page of R3 Stem Cell, a commercial regenerative medicine network offering injection-based stem cell, exosome and platelet treatments for joint pain and other conditions.
R3 Stem Cell Austin is one location in a commercial regenerative medicine network that the company's website says runs more than 80 centres across eight countries. The Austin page is a network location page rather than a site belonging to an independent practice, and it describes treatments the network offers generally rather than a named local practice with its own staff and premises.
According to the site, treatment is delivered as minimally invasive injections using either the patient's own tissue or donated birth tissue, and it lists mesenchymal stem cells (a cell type found in tissues such as bone marrow, fat and umbilical cord), platelet rich plasma (PRP, prepared from the patient's own blood), exosomes (small particles released by cells), growth factors and microRNAs. The network states that it has carried out more than 29,000 procedures in the past decade and that its umbilical tissue is obtained ethically and processed at laboratories it describes as cGMP (current good manufacturing practice) and ISO certified. These are the company's own statements and the page offers no independent evidence for them.
Readers comparing options should note what this page does not provide. It names no treating doctor at the Austin location, referring only to licensed providers in general, and it gives no street address, no facility description and no opening hours. It publishes no prices. Elsewhere the network claims an 85 per cent success rate in improving quality of life; that is a marketing claim made by the company, it is not broken down by condition or independently verified, and it should not be read as evidence that any particular treatment works. Stem cell therapies for most of the conditions listed remain investigational.
Anyone considering this clinic would need to ask directly who the treating physician is and what their credentials are, exactly which cell product would be used and where it comes from, what the total cost is, and what evidence exists for their specific condition.
The site groups the conditions it says may benefit into joint and spine problems plus a range of whole-body conditions.
The site says its treatments use mesenchymal stem cells taken from ethically donated birth tissue, alongside preparations made from the patient's own blood.
The Austin page names no clinician, which is a notable gap for a reader trying to check credentials.
The page gives no description of the Austin premises: there is no street address, no account of the treatment rooms or equipment, and no opening hours. It presents Austin as one point in a national and international network and directs enquiries to a central telephone number and an online find-a-doctor tool rather than to a named local office. A prospective patient would have to telephone to find out where treatment would actually take place and whether it is a dedicated clinic or space within another practice.
No prices are published for the Austin location. The network states that stem cell therapy is not covered by insurance and is paid for out of pocket, and that financing may be available to qualifying patients through third party lenders. A prospective patient would have to attend a free consultation to be quoted a cost, so the total price cannot be compared with other providers from the website alone.
Profile compiled from information published on the clinic's own website and from the StemCell Registry directory record. Details may change; confirm directly with the clinic before making decisions.